In breast cancer, Bassiouni et al. reported that CCT protein level could predict therapeutic application of a cytotoxic peptide [13], and further study shows CCT2 subunit is highly expressed in breast cancer and inversely corelates with patient survival, cells expression CCT2 were more invasive and proliferative. Here, FLVCR2 is linked to breast carcinoma.